Cargando…

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases

BACKGROUND: Beneficial response to first-line immunosuppressive azathioprine in patients with inflammatory bowel disease (IBD) is low due to high rates of adverse events. Co-administrating allopurinol has been shown to improve tolerability. However, data on this co-therapy as first-line treatment ar...

Descripción completa

Detalles Bibliográficos
Autores principales: van Liere, Elsa L. S. A., Bayoumy, Ahmed B., Mulder, Chris J. J., Warner, Ben, Hayee, Bu, Mateen, Bilal A., Nolan, Jonathan D., de Boer, Nanne K. H., Anderson, Simon H. C., Ansari, Azhar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287424/
https://www.ncbi.nlm.nih.gov/pubmed/34729677
http://dx.doi.org/10.1007/s10620-021-07273-y